Related Experiment Video
Updated: May 6, 2026

Candida albicans Biofilm Chip CaBChip for High-throughput Antifungal Drug Screening
Published on: July 18, 2012
Invasive Candidiasis: A Promising Approach Using Jatropha Dioica Extracts and Nanotechnology
Carlos Fernández-Villascan1, Rosalba Patiño-Herrera1, Ivonne Patino1
1Departamento de Ingeniería Química, Instituto Tecnológico de Celaya, Tecnológico Nacional de México, Av. Tecnológico y Antonio García Cubas Poniente #600, Celaya, Guanajuato, 38010, México.
Abstract:
Candida albicans, a common fungal organism, often lives harmlessly in the human body. However, under certain conditions, it can turn into a dangerous pathogen, causing infections that range from mild to life-threatening. With rising resistance to antifungal treatments, understanding and controlling this opportunistic fungus has never been more crucial. This study highlights the potential of combining natural plant extracts, specifically the aqueous (JdextAq) and ethanolic (JdextEt) extracts of Jatropha dioica, with nanotechnology in the form of magnetite nanoparticles (MNPs) to combat this persistent pathogen. FTIR spectra revealed significant interactions between the metabolites and MNPs, specifically through binding to the Fe3+ and Fe2+ sites. The average size of the MNPs was 11±3 nm, and they are non-toxic even at high concentration (500 μg/ml). The same effect is observed with JdextEt; however, JdextAq is cytotoxic at this concentration. The JdextAq-MNPs hybrid is toxic even at very low concentrations (250-50 μg/ml). All materials demonstrated high inhibition against C. albicans. At safe concentrations for cell viability, MNPs (500 μg/ml) and JdextEt-MNPs (500-50 μg/ml) achieved the highest inhibition rates of 97.13 % and 97.56 %, respectively. As antifungal resistance rises, these findings pave the way for innovative therapeutic strategies against this opportunistic pathogen.
Insights
This study explores combining Jatropha dioica plant extracts with magnetite nanoparticles (MNPs) to combat Candida albicans infections. The Jatropha dioica ethanolic extract-MNP combination shows high antifungal activity at safe concentrations.
Area of Science:
- Biotechnology
- Nanotechnology
- Mycology
Background:
- Candida albicans is an opportunistic pathogen causing infections.
- Rising antifungal resistance necessitates novel therapeutic strategies.
- Natural products and nanotechnology offer potential solutions.
Purpose of the Study:
- To investigate the synergistic antifungal effects of Jatropha dioica extracts and magnetite nanoparticles (MNPs) against Candida albicans.
- To evaluate the toxicity and efficacy of these combined materials.
Main Methods:
- Preparation and characterization of Jatropha dioica aqueous (JdextAq) and ethanolic (JdextEt) extracts.
- Synthesis and characterization of magnetite nanoparticles (MNPs).
- Fourier-transform infrared spectroscopy (FTIR) to analyze metabolite-MNP interactions.
- Antifungal inhibition assays against Candida albicans.
- Cytotoxicity assessments on cell viability.
Main Results:
- FTIR confirmed metabolite binding to MNPs at Fe2+ and Fe3+ sites.
- MNPs (11±3 nm) were non-toxic at 500 μg/ml; JdextAq was cytotoxic at this concentration.
- The JdextAq-MNP hybrid exhibited toxicity at low concentrations (50-250 μg/ml).
- Both MNPs and JdextEt-MNPs demonstrated high inhibition rates (>97%) against C. albicans at safe concentrations.
Conclusions:
- Jatropha dioica extracts combined with MNPs show significant potential as antifungal agents.
- The JdextEt-MNP formulation is effective and non-toxic, offering a promising therapeutic strategy.
- These findings contribute to developing new approaches against drug-resistant Candida albicans.
Related Concept Videos
Bioremediation
Bioavailability Enhancement: Drug Permeability Enhancement
Microbial Bioremediation of Hydrocarbons
Microbial Bioremediation of Pesticides
Production of Biopesticides
Antifungal Agents

